Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart watches and sensors track oxygen use in COPD patients

NCT ID NCT05473780

Knowledge-focused Sponsor: Vivisol Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well people with severe COPD follow their prescribed long-term oxygen therapy. Researchers used a special device on oxygen sources and a connected watch to track daily oxygen use and physical activity. The goal was to give doctors better information between regular check-ups, which are often months apart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

159 people

The number who actually took part.

Started

Jan 2023

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Cohort of COPD patients who initiate long-term oxygen therapy.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * COPD patients who require the initiation of a long term oxygen therapy. * Patient agreeing to use a connected watch and a TeleOx for the remote monitoring of their parameters and physical activity. * Non-smoker, ex-smoker, or patient agreeing to stop smoking. * Life expectancy greater than 6 months. * Signed informed consent form, * Subject affiliated to a health insurance system, or is a beneficiary. Exclusion Criteria: * Patient initiated on oxygen therapy prior to the inclusion visit. * Patient with cognitive impairment. * Simultaneous participation in a health intervention research, * Vulnerable subjects.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease

Contacts and locations

Locations

  • AP-HM Hopital nord

    Marseille, France

  • CH Avignon

    Avignon, France

  • CH Bligny

    Briis-sous-Forges, France

  • CH Blois

    Blois, France

  • CH Cannes

    Cannes, France

  • CH Draguignan

    Draguignan, 83007, France

  • CH Emile Roux

    Le Puy-en-Velay, 43000, France

  • CH Libourne

    Libourne, France

  • CH Louis Giorgi d'Orange

    Orange, 84100, France

  • CH Nord Ardèche

    Annonay, 07103, France

  • CH St Nazaire

    Saint-Nazaire, 44600, France

  • CH de Martigues

    Martigues, 13698, France

  • CH de Perpignan

    Perpignan, 66000, France

  • CHIAP

    Aix-en-Provence, France

  • CHRU Nancy-Université de Lorraine

    Nancy, 54511, France

  • CHU Gabriel Montpied

    Clermont-Ferrand, 63000, France

  • CHU de Bordeaux

    Pessac, 33600, France

  • Cabinet de Pneumologie

    Toulon, France

  • Cabinet libéral

    Avignon, France

  • Cabinet libéral

    Foix, France

  • Cabinet libéral

    Le Puy-en-Velay, France

  • Cabinet libéral

    Poissy, France

  • Cabinet privé

    Antibes, France

  • Centre médical Parot

    Lyon, France

  • Clinique Pasteur

    Toulouse, 31000, France

  • GHI Le Raincy

    Montfermeil, France

  • GHSIF / CH Melun

    Melun, 77000, France

  • Hopital Privé de La Casamance

    Aubagne, 13400, France

  • Hôpital La Louvière

    Lille, 59800, France

  • Hôpital Percy

    Clamart, 92140, France

  • Hôpital Saint Joseph

    Marseille, 13285, France

  • Hôpital d'Instruction des Armées Laveran

    Marseille, 13384, France

  • MGEN

    Sainte-Feyre, France

  • Pneumology practice

    Perpignan, 66000, France

  • Polyclinique des fleurs

    Ollioules, France

  • cabinet du dr Radu Horia Bumbea

    Sallanches, 74600, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.